• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型补体受体(CR2)的功能和抗原特性。

Functional and antigenic properties of complement receptor type 2, CR2.

作者信息

Mitomo K, Fujita T, Iida K

出版信息

J Exp Med. 1987 May 1;165(5):1424-9. doi: 10.1084/jem.165.5.1424.

DOI:10.1084/jem.165.5.1424
PMID:2437238
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2188314/
Abstract

This is the first report demonstrating that C3d receptor (CR2) has functional activity in regulating complement cascade. Purified CR2 was examined for its cofactor activity in factor I-mediated cleavage of membrane-bound iC3b. CR2 plus C3b inactivator (I) released C3c from EA 125I-iC3b, and the release was inhibited when CR2 was preincubated with OKB7 monoclonal anti-CR2. Furthermore, immunoelectroblotting analysis showed crossreactivity of CR2 with 57H anti-CR1. These results indicate that CR2 has functional and antigenic similarity to CR1, thus providing a supporting evidence for placement of CR2 as a member of the recently defined gene family of C3- and C4-regulatory proteins composed of CR1, C4-binding protein, and factor H.

摘要

这是首份证明C3d受体(CR2)在调节补体级联反应中具有功能活性的报告。检测了纯化的CR2在I因子介导的膜结合iC3b裂解中的辅因子活性。CR2加C3b灭活剂(I)可从EA 125I-iC3b中释放出C3c,当CR2与OKB7单克隆抗CR2预孵育时,这种释放受到抑制。此外,免疫印迹分析显示CR2与57H抗CR1有交叉反应性。这些结果表明CR2与CR1在功能和抗原性上相似,从而为将CR2归为最近定义的由CR1、C4结合蛋白和H因子组成的C3和C4调节蛋白基因家族成员提供了支持证据。

相似文献

1
Functional and antigenic properties of complement receptor type 2, CR2.2型补体受体(CR2)的功能和抗原特性。
J Exp Med. 1987 May 1;165(5):1424-9. doi: 10.1084/jem.165.5.1424.
2
Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.中性粒细胞表达一种与CR1、CR2和CR3不同的iC3b、C3dg和C3d受体。
J Immunol. 1985 Apr;134(4):2571-9.
3
Enhanced binding of immune complexes processed by erythrocyte CR1 (CD 35) receptors to purified CR2 (CD 21) receptors from tonsillar mononuclear cells.经红细胞CR1(CD 35)受体处理的免疫复合物与来自扁桃体单个核细胞的纯化CR2(CD 21)受体的结合增强。
APMIS. 1989 Apr;97(4):374-80. doi: 10.1111/j.1699-0463.1989.tb00803.x.
4
Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor.小鼠2型补体受体的特性及其与1型受体的免疫交叉反应性
Int Immunol. 1990;2(7):651-9. doi: 10.1093/intimm/2.7.651.
5
Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement.人B淋巴细胞C3d/爱泼斯坦-巴尔病毒受体部分cDNA克隆的鉴定:与补体第三和第四成分C3b及C4b片段受体的同源性
Proc Natl Acad Sci U S A. 1986 Aug;83(15):5639-43. doi: 10.1073/pnas.83.15.5639.
6
Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.补体受体CR1在与免疫复合物相关的C3b降解中的独特作用。
J Exp Med. 1982 Dec 1;156(6):1739-54. doi: 10.1084/jem.156.6.1739.
7
The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models.人类补体受体 2(CR2)/CR1 融合蛋白 TT32 是一种新型靶向抑制剂,可抑制经典途径和替代途径的 C3 转化酶,可预防主动免疫和被动转移小鼠模型的关节炎。
Mol Immunol. 2019 Jan;105:150-164. doi: 10.1016/j.molimm.2018.09.013. Epub 2018 Dec 1.
8
Interaction of iC3b with recombinant isotypic and chimeric forms of CR2.iC3b与CR2的重组同型和嵌合形式的相互作用。
J Immunol. 1991 Jul 15;147(2):590-4.
9
Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.鉴定一种145,000道尔顿的膜蛋白为人B淋巴细胞的C3d受体(CR2)。
Proc Natl Acad Sci U S A. 1984 Feb;81(3):881-5. doi: 10.1073/pnas.81.3.881.
10
Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2).人B淋巴细胞上C3受体活性分析及2型补体受体(CR2)的分离
Biochem J. 1984 Nov 15;224(1):75-86. doi: 10.1042/bj2240075.

引用本文的文献

1
CD46 knock-out using CRISPR/Cas9 editing of hTERT immortalized human cells modulates complement activation.使用 CRISPR/Cas9 编辑 hTERT 永生化人细胞敲除 CD46 可调节补体激活。
PLoS One. 2019 Apr 8;14(4):e0214514. doi: 10.1371/journal.pone.0214514. eCollection 2019.
2
Therapeutic uses of recombinant complement protein inhibitors.重组补体蛋白抑制剂的治疗用途。
Springer Semin Immunopathol. 1994;15(4):417-31. doi: 10.1007/BF01837368.
3
Epstein-Barr virus regulates activation and processing of the third component of complement.爱泼斯坦-巴尔病毒调节补体第三成分的激活和加工。
J Exp Med. 1988 Sep 1;168(3):949-69. doi: 10.1084/jem.168.3.949.
4
Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins.人C3d和爱泼斯坦-巴尔病毒B淋巴细胞受体的结构及其与C3/C4结合蛋白家族其他成员的相关性。
J Exp Med. 1988 Mar 1;167(3):1047-66. doi: 10.1084/jem.167.3.1047.
5
Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells.补体膜辅因子蛋白存在于人类成纤维细胞、上皮细胞和内皮细胞上。
J Clin Invest. 1989 Aug;84(2):538-45. doi: 10.1172/JCI114196.
6
Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides.单克隆抗体检测补体成分C3中的新抗原。用合成肽对识别表位进行定位。
Biochem J. 1990 May 15;268(1):55-61. doi: 10.1042/bj2680055.

本文引用的文献

1
Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.补体受体CR1在与免疫复合物相关的C3b降解中的独特作用。
J Exp Med. 1982 Dec 1;156(6):1739-54. doi: 10.1084/jem.156.6.1739.
2
Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.利用单克隆抗体鉴定补体片段C3d的膜受体。
J Exp Med. 1983 Oct 1;158(4):1021-33. doi: 10.1084/jem.158.4.1021.
3
Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.用纯化的I因子或血清生成结合C3的三种不同片段。II. C3片段中B因子、H因子、补体受体和牛胶固素结合位点的定位。
J Exp Med. 1983 Aug 1;158(2):334-52. doi: 10.1084/jem.158.2.334.
4
Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.人类B淋巴细胞的爱泼斯坦-巴尔病毒受体是C3d受体CR2。
Proc Natl Acad Sci U S A. 1984 Jul;81(14):4510-4. doi: 10.1073/pnas.81.14.4510.
5
Human lymphocytes bear membrane receptors for C3b and C3d.人类淋巴细胞带有C3b和C3d的膜受体。
J Clin Invest. 1973 Dec;52(12):3239-42. doi: 10.1172/JCI107525.
6
Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b.人类淋巴细胞上的两种不同补体受体。一种对C3b具有特异性,另一种对C3b灭活剂裂解的C3b具有特异性。
J Exp Med. 1973 Oct 1;138(4):798-811. doi: 10.1084/jem.138.4.798.
7
Growth control of activated, synchronized murine B cells by the C3d fragment of human complement.人补体C3d片段对活化的、同步化的小鼠B细胞的生长控制
Nature. 1985;317(6034):264-7. doi: 10.1038/317264a0.
8
Molecular cloning and characterization of the cDNA coding for C4b-binding protein, a regulatory protein of the classical pathway of the human complement system.人补体系统经典途径调节蛋白C4b结合蛋白编码cDNA的分子克隆与特性分析
Biochem J. 1985 Aug 15;230(1):133-41. doi: 10.1042/bj2300133.
9
Human genes for three complement components that regulate the activation of C3 are tightly linked.调控C3激活的三种补体成分的人类基因紧密连锁。
J Exp Med. 1985 May 1;161(5):1189-95. doi: 10.1084/jem.161.5.1189.
10
Enhancement of human B cell proliferation by an antibody to the C3d receptor, the gp 140 molecule.通过针对C3d受体gp 140分子的抗体增强人B细胞增殖。
Eur J Immunol. 1985 Jan;15(1):73-6. doi: 10.1002/eji.1830150114.